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Abstract
Background: The Agilent microRNA microarray platform interrogates each microRNA with several copies of distinct
oligonucleotide probes and integrates the results into a total gene signal (TGS), using a proprietary algorithm that
makes use of the background subtracted signal. The TGS can be normalized between arrays, and the Agilent
recommendation is either not to normalize or to normalize to the 75
th percentile signal intensity. The robust
multiarray average algorithm (RMA) is an alternative method, originally developed to obtain a summary measure of
mRNA Affymetrix gene expression arrays by using a linear model that takes into account the probe affinity effect.
The RMA method has been shown to improve the accuracy and precision of expression measurements relative to
other competing methods. There is also evidence that it might be preferable to use non-corrected signals for the
processing of microRNA data, rather than background-corrected signals. In this study we assess the use of the RMA
method to obtain a summarized microRNA signal for the Agilent arrays.
Findings: We have adapted the RMA method to obtain a processed signal for the Agilent arrays and have
compared the RMA summarized signal to the TGS generated with the image analysis software provided by the
vendor. We also compared the use of the RMA algorithm with uncorrected and background-corrected signals, and
compared quantile normalization with the normalization method recommended by the vendor. The pre-processing
methods were compared in terms of their ability to reduce the variability (increase precision) of the signals
between biological replicates. Application of the RMA method to non-background corrected signals produced
more precise signals than either the RMA-background-corrected signal or the quantile-normalized Agilent TGS. The
Agilent TGS normalized to the 75% percentile showed more variation than the other measures.
Conclusions: Used without background correction, a summarized signal that takes into account the probe effect
might provide a more precise estimate of microRNA expression. The variability of quantile normalization was lower
compared with the normalization method recommended by the vendor.
Background
MicroRNAs are a family of small single-stranded non-
coding RNAs which regulate gene expression [1]. Func-
tional studies show that microRNAs participate in vir-
tually every cellular process investigated, and changes in
their expression might underlie many human patholo-
gies [2]. The main research tool for identifying micro-
RNAs involved in specific cellular processes is gene
expression profiling using microarray technology. The
microRNA Agilent microarrays [3] use different oligonu-
cleotide probes for each individual microRNA that are
replicated a number of times across the array surface.
The Agilent Feature Extraction image analysis software
(AFE) computes a summary measure for each micro-
RNA, referred to as total gene signal (TGS), based on
the robust average of all the background subtracted
signals for each replicated probe. To make statistical
inferences, Agilent recommends using either the non-
normalized TGS or the TGS normalized to the 75
th per-
centile signal intensity, and several studies have pointed
out that data normalization improves sensitivity and
specificity over non-normalized microRNA data [4,5].
An alternative approach is to use the robust multiarray
average (RMA) algorithm, developed by Irizarry et al.
[6] as a novel method to obtain a summary measure
from the probe level data for Affymetrix mRNA arrays.
The RMA algorithm was shown to outperform other
methods for summarizing multiple probe level data into
a single gene expression measure [6]. In our study, we
took advantage of the probe replication in the Agilent
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summarize the microRNA Agilent probe level data into
a single processed and normalized microRNA signal
estimate. We compared different signal processing
methods: the adapted RMA method; the AFE-TGS
method with normalization to the 75
th percentile, as
recommended by the vendor; and the AFE-TGS normal-
ized by the quantile method [7,8]. Irizarry et al. (unpub-
l i s h e d )c o m p a r e dt h ep e r f o r m a n c eo fd i f f e r e n t
microRNA array platforms and pointed out that back-
ground correction might increase the false positive
detection of fold changes for low expressed microRNAs.
Therefore we tested the RMA method using probe level
data with and without background correction. The dif-
ferent signal processing methods were evaluated in
terms of their ability to reduce variability between biolo-
gical replicates.
Methods
RNA samples
We used two independent microRNA gene expression
data sets. The first (dat1) comprises 8 samples obtained
in our lab and the second (dat2) contains 31 samples
obtained from GEO database [9]. The dat1 set com-
prises the microRNA gene expression profiles of bone
marrow-derived human mesenchymal stem cells
(hMSCs) and human dermal fibroblasts, obtained from
4 independent donors for each tissue. Total RNA was
isolated using the miRNeasy kit (Qiagen). 100 ng of
each RNA sample were hybridized to Agilent Human
microRNA Microarray v2.0 (G4470B, Agilent Technolo-
gies). MicroRNA labeling, hybridization and washing
were carried out following Agilent’s instructions. Images
of hybridized microarrays were acquired with a DNA
microarray scanner (Agilent G2565BA), and features
were extracted using the AFE image analysis tool ver-
sion A.9.5.3.1 with default protocols and settings [10].
The hMSCs and dermal fibroblasts used in our study
have been deposited in the GEO database [9] (accession
number GSE19232) and the corresponding raw data can
be retrieved from the supplementary file (GSM476577.
txt.gz): MSC_rep1, Fib_rep1, MSC_rep2, Fib_rep2,
MSC_rep3, Fib_rep3, MSC_rep4 and Fib_rep4. Since the
number of replicates in dat1 might be too low to pro-
vide compelling evidence, we also analyzed a larger data
set (dat2), also hybridized to the Agilent Human micro-
RNA microarray v2.0 (G4470B, Agilent Technologies).
dat2 was selected from the raw data deposited in the
supplementary file of the GEO GSE16444 series. dat2 is
made up of 31 samples from stage 4 neuroblastoma
patients: 17 from long survivors and 14 from short sur-
vivors. As with the hMSC and dermal fibroblast data,
the slides used in the GSE16444 series were scanned
with an Agilent G2565BA scanner according to the
microRNA Microarray System protocol, and the raw
data were obtained with the Agilent Feature Extraction
software v. 9.5.3.1 (Agilent Technologies).
Agilent microRNA microarray
Agilent microRNA assays integrate eight individual
microarrays on a single glass slide. Each microarray
includes approximately 15 k features containing probes
sourced from the miRBASE public database [11]. The
probes are 60-mer oligonucleotides directly synthesized
on the array. In this study we used Human microRNA
microarray v2.0, which contains 723 human and 76
human viral microRNAs, each replicated 16 times. 362
microRNAs are interrogated by 2 different oligonucleo-
tides, 45 microRNAs by 3, and 390 microRNAs by 4.
Only 2 microRNAs are interrogated by a single oligonu-
cleotide. The array also contains a set of positive and
negative controls that are replicated a variety of times.
Some of the positive control probes target non-micro-
RNA human RNAs. Each of these targets was interro-
gated with 4 different probes, which are repeated
5 times. The signals from these positive controls can be
bright or dim depending on the sample, and according
to Agilent they do not behave consistently enough to be
used for normalization.
Agilent total gene signal
The AFE algorithms estimate a single intensity measure
for each microRNA, referred to as the total gene signal
(TGS). The AFE-TGS is estimated by multiplying the
total probe signal by the number of probes per gene.
The total probe signal is the robust average of all the
background-subtracted signals for each replicated probe
multiplied by the total number of probe replicates.
Usually the background signal is the sum of the median
local background signal plus the spatial detrending sur-
face value computed by AFE, which estimates the noise
due to a systematic gradient on the array.
Signal Processing
All the methods used in the study were implemented in R
[12] using functions and packages collected in the Bio-
conductor project [13] as well as custom written routines.
Agilent microRNA microarrays interrogate each micro-
RNA with multiple probe sets. The statistical inference
requires a processed signal, which is an estimate of the
expression measure for every microRNA that can be nor-
malized between arrays. We considered 4 processed sig-
nals: a) the AFE-TGS normalized to the 75
th percentile
(nor75); b) the AFE-TGS normalized by the quantile
method (norQ); c) the adapted RMA algorithm using a
background-corrected signal based on the exponential-
normal convolution model [6] (norRMAbg) ;a n dd )t h e
RMA method without background correction (norRMA).
Negative values in the AFE-TGS were converted into
positive signals by adding the quantity |min (AFE-TGS)|
+ 2 before log transformation. The processed nor75
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Page 2 of 6signal was obtained for every array by dividing the
AFE-TGS by the 75th percentile of the signal for that
particular array. This guarantees that the adjusted signals
will all have a 75
th percentile equal to 1. The reason for
using the 75
th percentile rather than other statistical
measures such as the mean is to diminish the possible
influence of outliers. The median could be used instead,
b u ti fw ea s s u m et h a ta b o u th a l fo ft h eg e n e sw i l ln o t
show any significant expression, the 75th percentile will
represent the median of the remaining 50% that are
expressed. The norQ was obtained by using the normali-
zeBetweenArrays function from the Bioconductor limma
package [14]. norRMAbg and norRMA estimate the
expression of a given microRNA from all the probe mea-
sures for that microRNA. The RMA algorithm was
applied in the following sequential steps. For norRMAbg
only, the raw mean signal was first background corrected
by the exponential + normal convolution model [6],
using the rma.background.correct function of the Biocon-
ductor preprocessCore package [15]. norRMAbg and
norRMA signals were then normalized between arrays by
quantile normalization using the normalizeBetweenAr-
rays function [13]. The signals were log 2 transformed,
and the median of the replicated probes was obtained,
normally yielding 2, 3 or 4 different measures (probe
level data) for each microRNA; these measures were
summarized into a single microRNA measure with the
rma_c_complete_copy function of the affy package [16].
For each feature, the RMA estimates a unique signal by
fitting a linear model that takes into account the probe
effect. The estimates in the linear model are obtained
using the median polish algorithm.
Results and Discussion
We compared four methods for obtaining a processed
microRNA signal that can be used for statistical microar-
ray data analysis. The four processed signals analyzed
were a) the total gene signal estimated by AFE (AFE-TGS)
and normalized to the 75
th percentile (nor75), as recom-
mended by the vendor; b) the AFE-TGS normalized by
the quantile method [7,8] (norQ); c) the total gene signal
estimated by the RMA algorithm [6] using background-
corrected data (norRMAbg); and d) the total gene signal
estimated by the RMA algorithm using the raw probe-
level data without background correction (norRMA). Both
norRMAbg and norRMA incorporate the quantile normali-
zation approach [7,8]. The goal of the study was not to
compare different normalization methods, but rather to
compare different methods for obtaining a summarized
gene signal based on multiple probe level data, in this case
the AFE-TGS method provided by the vendor and the
RMA method, which can be used with or without back-
ground correction. Once a total gene signal was obtained,
we used the quantile method to normalize between arrays,
since this is one of the most robust methods for normaliz-
ing between microRNA arrays according to the literature
[4,5]. We did not consider other methods because our
goal was not to compare normalization methods, but to
obtain a summarized measure of microRNA expression
from multiple probe level data. For the AFE-TGS we also
u s e dt h e7 5 %p e r c e n t i l e ,a st h i si so n eo ft h em e t h o d s
recommended by the vendor. The different signal pre-pro-
cessing methods were evaluated for their ability to reduce
the variability between biological replicates in the two data
sets. We computed the SD of the log2 expression values
for every feature across the biological replicates. We then
used natural cubic splines (5 knots) to fit curves to the
scatter plot of the SD values against the average expres-
sion values. Similar conclusions can be drawn from both
data sets. The nor75 signal has the largest variability
among replicates across almost all intensity ranges for
dat1 (figure 1), although for dat2 the norRMAbg has
slightly larger SD values for medium intensity values (fig-
ure 2). The norQ and the norRMAbg signals show
approximately the same variability for dat1 (figure 1). The
larger SD for medium intensity values obtained with norR-
MAbg in dat2 is due to the background correction. Inter-
estingly, the SD values obtained with uncorrected and
background-corrected signals in the RMA method follow
similar profiles, but the SD values are larger for the back-
ground-corrected signals. The same pattern can be seen in
dat1, but in this data set the background correction seems
to increase signal variability to a much lesser extent. The
norRMA signal has the smallest variability for both data
sets. For high intensity values, the norQ, norRMA and
norRMAbg curves overlap, especially for the dat1 data set,
suggesting that the choice of one method over another
might have more influence on the detection of low-
expressed microRNAs. After obtaining the normalized sig-
nals from dat1, we removed the positive and negative con-
trols and the microRNA genes that were not expressed in
either of the two experimental groups (hMSCs and fibro-
blasts) according to the IsGeneDetected flag provided by
AFE algorithms. After this filtering step only 284 out of
799 microRNA genes were retained, as considered to be
expressed in at least one experimental group. To study the
overall effect of the different pre-processing methods we
generated relative log expression (RLE) boxplots for the
284 expressed microRNAs (figure 3). The RLE boxplots
plot the differences between the processed microRNA sig-
nals from each array and the median of the same signals
across all the arrays [17]. The RLE boxplots should be
centered on zero and all of them should have approxi-
mately the same dispersion. The RLE of the non-normal-
ized AFE-TGS shows a high dispersion between arrays,
and it is also evident that the hMSC samples have an
overall higher intensity than the fibroblasts. The 75% per-
centile normalization (nor75) tends to push the sample
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Page 3 of 6Figure 1 Signal variability for dat1. Smooth curves fitted to the scatter plots of SD values for biological replicates against the average
expression of each gene (log2 scale) in the dat1 data set (8 arrays). Curves were fitted using natural cubic splines with 5 knots.
Figure 2 Signal variability for dat2. Smooth curves fitted to the scatter plots of SD values for biological replicates against the average
expression of each gene (log2 scale) in the dat2 data set (GEO accession number GSE16444, 31 arrays). Curves were fitted using natural cubic
splines with 5 knots.
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mesenchymal and fibroblast samples can still be observed.
After normalizing the AFE-TGS by quantiles (norQ)a l l
the boxplots are centered on zero and have a similar dis-
persion. Boxplots generated with the RMA algorithm data
also centered on zero. This is not surprising since the
RMA method incorporates the quantile algorithm, but the
RMA algorithm seems to further reduce the variability of
the signals in comparison with the norQ signal. The
variability was especially reduced for the RMA method
with no background correction (norRMA). This effect was
also pointed out by Irizarry et al. (unpublished).
Conclusions
Taking advantage of the probe replication in Agilent
microRNA arrays, we have adapted the RMA algorithm
to obtain a summary microRNA signal that takes into
account the probe affinity effect. In addition, since there
Figure 3 Relative log expression boxplots for dat1. RLE plots (described in the text) for the total gene signals estimated by different
methods. AFE-TGS, AFE-TGS without normalization between arrays. nor75, the AFE-TGS normalized to the 75
th percentile. norQ, AFE-TGS
normalized by quantiles. norRMAbg, total gene signal estimated by the RMA algorithm using background-corrected probe-level data. norRMA,
total gene signal estimated by the RMA algorithm using raw probe-level data without background correction. M, hMSC samples; F, human
dermal fibroblast samples.
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yield less variable results than methods that use back-
ground-corrected signals (Irizarry et al. unpublished), we
applied the RMA algorithm to uncorrected and back-
ground-corrected signals, both normalized by quantiles
[7,8]. The RMA of the non background-corrected signal
showed lower variability between replicates than either
the RMA of the background-corrected signal or the
quantile-normalized AFE-TGS [7,8], especially for the
dat1 data set. For the dat2 data set the RMA of the non
background-corrected signal still showed lower variability
than the AFE-TGS normalized by quantiles, although the
differences in this case were smaller. The high signal
variability obtained for dat2 with background correction
in the RMA method suggests that an RMA method using
a non background corrected signal might be preferable.
The RMA of the non background-corrected signal and
the AFE-TGS normalized by quantiles were almost
equally precise, but the RMA seems to produce signals of
lower variability at low intensity values. The use of the
RMA algorithm with an uncorrected signal might thus be
advantageous for the detection of low expressed genes.
Finally, the AFE-TGS normalized to the 75% percentile
showed the highest signal variability of all methods
tested, indicating that quantile normalization yields lower
signal variability than the method recommended by the
vendor.
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